Form 4 for DNTH Dianthus Therapeutics, Inc. /DE/
Accepted 2022-12-02 00:00:00 ET · period of report 2022-11-30 · accession 0000899243-22-037433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-02 | 2022-11-30 | DNTH | Mahoney Stephen F. | See Remarks | A - Grant | $0.94 | +3,000 | 17.3K | +21% | +$2,820 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-30 | A | A | 3,000 | $0.94 | 17,264 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 1, 2022. |